Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

In Vitro Eye Irritation or Serious Eye Damage Test : Reconstructed human Cornea-like Epithelium (RhCE)

In Vitro Eye Irritation or Serious Eye Damage Test : Reconstructed human Cornea-like Epithelium (RhCE)

The in vitro eye irritation test is used to evaluate the eye hazard potential of a test chemical based on its ability to induce cytotoxicity in a RhCE tissue construct as measured by the tetrazolium dye.

Test model EpiOcular Tissues
Replicates N=2 tissues per test condition
Assay controls Negative control: Ultrapure water
Positive control: Methyl acetate
Exposure time 6 hours (±0.25 h) – Solids
30 min (±2 min) – Liquids
50 μL or 50 mg of test material per tissue
Test item quantity 0.5 ml or 500 mg
End point MTT Tissue viability assay
Data delivery % relative viability ± SD
Timeline 15 days

Acceptable OD value for EpiDerm model:

  • Lower acceptance limit: ≥ 0.8
  • Upper acceptance limit: ≤ 2.8
Mean tissue viability (%) Data prediction
≤ 60% Irritant (I)
> 60% Non-irritant (NI)

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details